Sucralose, Stevia, Gut Microbiome and Glucose Metabolism
Public ClinicalTrials.gov record NCT02800707. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will determine the influence of two non-caloric sweeteners on glucose metabolism via the gut microbiome in adult men and women.
Study identification
- NCT ID
- NCT02800707
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 40 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 35 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2, 2017
- Primary completion
- Jan 30, 2018
- Completion
- Jan 30, 2018
- Last update posted
- Mar 21, 2018
2017 – 2018
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| ECRC | Minneapolis | Minnesota | 55454 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Impaired Glucose Tolerance trials
Other public records listing Impaired Glucose Tolerance. Sorted by last update posted; newest first. Not a recommendation.
- NCT06507722: Night Owl Metabolism Recruiting
- NCT05067621: Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease Active, not recruiting
- NCT05387551: CGM and Lifestyle Changes in Patients With Impaired Glucose Tolerance Recruiting
- NCT03938389: The Renin-Angiotensin-Aldosterone System in Adiposity, Blood Pressure and Glucose in African Americans Active, not recruiting
- NCT05912348: The Effects of an Obesogenic Lifestyle in Recreationally Active, Young Adults Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02800707, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 21, 2018 · Synced Sep 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02800707 live on ClinicalTrials.gov.